Video Shorts

VISIONARY Trial: Sibeprenlimab Nearly Flattens eGFR Decline in IgA Nephropathy at 2 Years, With Dana Rizk, MD

Microneedle Peanut Allergy Patch: What's Next

Hair Regrowth: New Data on Upadacitinib for Severe Alopecia Areata

A 3-Minute Skin Stamp for Peanut Allergy?

When You're Ready to Lead in Medicine

Why Mentorship is the Secret to Career Success

1 Year of Brensocatib: Evolving Bronchiectasis Care

VISIONARY Trial: Sibeprenlimab Stabilizes eGFR Decline at 2 Years in IgA Nephropathy

Why Is Access to Esketamine Clinics So Uneven?

Understanding U700 Insulin Dosing

TMS, ECT, or VNS: Who's a Candidate for Neuromodulation?

How to Titrate Once-Weekly Insulin

Beyond Esketamine: What's Next for Rapid Depression Relief?

The Future of Type 1 Diabetes: Continuous Ketone Monitoring

How Long Should a Failed Antidepressant Trial Actually Run?

A Simpler Way to Manage Diabetes: The New 7-Day Patch Pump

Managing Antidepressant Adverse Events Without Stopping Treatment

Can Moisturizers Prevent Pediatric Eczema?

Can Nonstick Pans Increase IBD Risk?

Who to Select for Viral Prophylactic COVID-19 Therapy?

Why COVID-19 Boosters Are Still Important

Why Food Allergies Lead to Eating Anxiety in Children

Planner vs. Spontaneous: Building Your Career

New Triple Agonist Drug Achieves 21% Weight Loss

Why Palforzia Failed: "There Was Always This Risk of Adverse Reactions"

Putting Diabetes into Remission: The Power of Early Intervention

The Need for Better Pediatric Skin Treatment

The Hidden Reality of Buying Weight Loss Drugs Online

The Evolution of GLP-1 Drugs In Kidney and Heart Health

Povorcitinib: A New Oral Option for HS